Advanced Search

 

Study ID Status Title Patient Level Data
SFCB1001 Completed A study to evaluate the safety, tolerability and systemic pharmacodynamic effects of salmeterol in the salmeterol/FP DISKUS™ inhaler
SFCB1002 Completed A study to evaluate the safety, tolerability, pharmacokinetics and systemic pharmacodynamic effects of fluticasone propionate in the salmeterol/fluticasone propionate DISKUS™ inhaler
SFCB1004 Completed The systemic pharmacodynamic effects and pharmacokinetics of salmeterol and fluticasone propionate when given alone and in combination, after repeat dosing from DISKUS™ inhalers in healthy volunteers
SFCB1005 Completed The systemic pharmacodynamic effects and pharmacokinetics of salmeterol and fluticasone propionate when given together, from either a single or two separate DISKUS™ inhalers, in single doses
SFCB3017 Completed A multicentre randomised, double-blind, double-dummy, parallel group comparison of the salmeterol/fluticasone propionate combination product (50/100mcg strength) BID via one DISKUS/ACCUHALER inhaler with salmeterol 50mcg BID via one DISKUS/ACCUHALER inhaler and fluticasone propionate 100mcg BID ...
SFCB3018 Completed A multicentre randomised, double-blind, double-dummy, parallel group six-month comparison of the salmeterol/fluticasone propionate combination product (50/250mcg strength) BID via one DISKUS/ACCUHALER inhaler with salmeterol 50mcg BID via one DISKUS/ACCUHALER inhaler and fluticasone propionate 2 ...
SFCB3019 Completed A multicentre randomized, double-blind, double-dummy, parallel-group comparison of the salmeterol/fluticasone propionate combination product (50/500mcg strength) BD via one DISKUS/Accuhaler inhaler with salmeterol 50mcg BD via one DISKUS/Accuhaler and fluticasone propionate 500mcg BD via another ...
SFCB3020 Completed A Multicentre, Randomized, Double-Blind, Double-Dummy, Parallel-Group, Comparison of the Salmeterol/Fluticasone Propionate Combination Product (50/100mcg strength) BD Via One DISKUS/ACCUHALER Inhaler with Salmeterol 50mcg BD Via One DISKUS/ACCUHALER and Fluticasone Propionate 100mcg BD Via a Sec ...
SFCB3022 Completed A multicentre, randomised, double-blind, double-dummy, parallel-group, three-month comparison of the salmeterol/fluticasone propionate combination product (2x25/50mcg strength) bd via the pressurised metered dose inhaler with salmeterol/fluticasone propionate combination product (1x50/100mcg str ...
SFCB3023 Completed A multicentre, randomised, double-blind, double-dummy, parallel-group, three-month comparison of the salmeterol/fluticasone propionate combination product (2x25/250mcg strength) bd via the pressurised metered dose inhaler with salmeterol/fluticasone propionate combination product (1x50/500mcg st ...
SFCB3024 Completed A multicentre, randomised, double-blind, parallel group study to compare the efficacy and safety of the Salmeterol/Fluticasone combination product (50/500mg strength) twice daily with Salmeterol 50mg twice daily alone and Fluticasone Propionate 500mg twice daily alone, all delivered via the Diskus/Accuhaler inhaler, in the treatment of patients with chronic obstructive pulmonary disease. Study Listed on ClinicalStudyDataRequest.com
SFCF4001 Completed Uncontrolled asthma in adults: comparison of combination FP/salmeterol (administered via Diskus) with doubling the dosage of inhaled corticosteroid + long acting ?2-mimetic or adding long acting ?2-mimetic to corticosteroid previously inhaled.
SFCF4002 Completed Asthma controlled by Seretide in adults with persistent moderate asthma : efficacy in preventing exacerbations and quality of life
SFCF4006 Completed Study of control of moderate to severe asthma with Seretide in general practice.
SFCF4007 Completed Comparison of the efficacy and safety of Seretide and beclomethasone dipropionate plus montelukast in asthma.
SFCF4020 Completed Asthma control: evaluation in adults during treatment with Seretide
SFCF4021 Completed Research of predictive factors for the response to Seretide® in chronic obstructive pulmonary disease patients with FEV1<50%
SIG102335 Completed Double-blind, placebo-controlled, 3-way crossover study to investigate the effect of 7-days repeat once daily inhaled doses of GW870086X administered via DISKHALER on airway responsiveness to AMP in mild steroid-naive male asthmatics
SIG103337 Completed A randomised, double-blind, placebo-controlled, incomplete block, 4-period crossover, study to investigate the effects of 5-day repeat inhaled doses of fluticasone propionate (BID, 50-2000 mcg) on airway responsiveness to adenosine 5-monophosphate (AMP) challenge when delivered after the last dose in mild asthmatic subjects. Study Listed on ClinicalStudyDataRequest.com
SK&F-105517/321 Completed A multicenter, placebo-controlled, 8-month study of the effect of twice daily carvedilol in children withcongestive heart failure due to systemic ventricular systolic dysfunction
SKF104864/722 Completed A Phase I Study of Oral Topotecan in Subjects with Cancer and Impaired Renal Function
SLG102 Completed A Double-Blind Evaluation of Efficacy, Safety, and Tolerability of Several Single Doses of Salmeterol Hydroxynaphthaote (GR33343G) Compared With Albuterol and Placebo in Asthmatic Patients
SLGA2002 Completed A randomized, double-blind, double-dummy, single-dose, three-way cross-over comparison of salmeterol xinafoate 50mcg and placebo given by the multi-dose powder inhaler and Diskhaler for the prevention of exercise-induced bronchospasm in adolescent and adult patients with asthma.
SLGA2004 Completed A randomized, double-blind, double-dummy, placebo-controlled, comparative clinical trial of salmeterol xinafoate via multi-dose powder inhaler versus salmeterol xinofoate via Diskhaler for four weeks in adolescent and adult subjects with mild-to-moderate asthma.
SLGA2014 Completed A randomized, double-blind, double-dummy, single-dose, four-way cross-over comparison of salmeterol 25mcg and 50mcg given by the multi-dose powder inhaler (DISKUSTM), albuterol 180mcg given by the metered-dose inhaler, and placebo for the prevention of exercise-induced bronchospasm in pediatric ...

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.